Author | Marra 2011[23] | Prowle 2011[4] | Valles 2011[24] | Corona 2010[25] | Tabah 2012[12] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(countries) | (Brazil) | (Australia) | (Spain, Argentina) | (Europe, Australasia, South America, Asia) | (Europe, South America, China, Canada) | ||||||
Type of BSI (number of cases) | HAB (1196) | ICU-AB (330) | CAB (343) | HCAB (131) | HAB (252) | CAB (431) | HAB (351) | ICU-AB (915) | HAB (279) | ICU-AB (877) | % MDROb |
S. pneumoniae | Â | Â | 21.4% | Â | Â | 10.9% | 1.4% | 0.4% | -- | -- | Â |
S. aureus | 12.8% | 26.7% | 10.3%a | 13.8%a | 9.6%a | 22.3% | 26.2% | 23.6% | 16.1% | 8.4% | 60% |
CoNS | 16.6% | 24.3% | 3.5% | 6.2% | 10.8% | 16.5% | 19.7% | 29.6% | 10% | 12.7% | -- |
Enterococcus spp. | 5.5% | 17% | 1.5% | 4.6% | 8.4% | 7.2% | 9.1% | 11.4% | 10% | 12.9% | 43.5% |
E. coli | Â | Gram negative 28.2% | 20.5% | 26.9 | 18.5% | 19% | 9.7% | 5.6% | 19% | 5.1% | 66.7% |
Enterobacter spp. | 5.8% | 2.3% | 6.9% | 3.6% | 2.6% | 4.8% | 6.3% | 7.2% | 7.6% | 50% | |
Klebsiella spp. | 11.8% | 4.1% | 4.6% | 6.0% | 4.6% | 8.6% | 8.5% | 8.2% | 15.2% | 90.9% | |
Serratia spp. | 3.2% | Â | Â | Â | Â | Â | Â | 1.8% | 2.6% | 69% | |
Proteus spp. | 1.8% | Â | Â | Â | 3.3% | 1.4% | 1.5% | 1.4% | 1.7% | 20% | |
P. aeruginosa | 10% | 1.8% | 4.6% | 6.4% | 6% | 10.3% | 9.7% | 10.4% | 12.5% | 60% | |
Acinetobacter spp. | 11.8% | Â | Â | Â | 0.9% | 5.4% | 5.7% | 7.5% | 15.7% | 95.2% | |
Anaerobes | Â | Â | 3.2% | 1.5% | 1.6% | Â | Â | Â | 3.9% | 0.7% | 0 |
Candida spp. | 5.8% | 15.5% | 1.5% | 3.8% | 8.4% | 4.9% | 10.5% | 6.5% | 7.5% | 8.2% | -- |